Acetagastrodin

Acetagastrodin
Product Name Acetagastrodin
CAS No.: 64291-41-4
Catalog No.: CFN80033
Molecular Formula: C21H26O11
Molecular Weight: 454.43 g/mol
Purity: >=98%
Type of Compound: Phenols
Physical Desc.: Powder
Source: The herbs of Gastrodia elata
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price:
Acetagastrodin has antispasmodic effect on vascular smooth muscle. Acetagastrodin treatment may be an effective treatment to protect retinal neurons against such functional impairment during the early stages of diabetes.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Plants (Basel).2021, 10(4):702.
  • Int J Mol Sci.2015, 16(8):18396-411
  • Anticancer Agents Med Chem.2023, 23(10):1204-1210.
  • Journal of Analytical Chemistry2017, 854-861
  • Eur J Pharmacol.2024, 981:176883.
  • J Appl Biol Chem.2022, 65(4):pp.463-469.
  • J Ginseng Res.2023, 47(4):593-603.
  • Nutrients2022, 14(3),695.
  • J Mater Chem B.2019, 7(39):5896-5919
  • J. Food Composition and Anal.2022, V 109:104482.
  • 4-(Ethoxymethyl)phenol

    Catalog No: CFN97879
    CAS No: 57726-26-8
    Price: Inquiry(manager@chemfaces.com)
    Gastrodin

    Catalog No: CFN99549
    CAS No: 62499-27-8
    Price: $30/20mg
    Acetagastrodin

    Catalog No: CFN80033
    CAS No: 64291-41-4
    Price: Inquiry(manager@chemfaces.com)
    Calleryanin

    Catalog No: CFN95556
    CAS No: 20300-53-2
    Price: $318/5mg
    Protocatechuic acid 4-O-beta-glucoside

    Catalog No: CFN95557
    CAS No: 7361-59-3
    Price: $413/5mg
    Odontoside

    Catalog No: CFN95530
    CAS No: 20300-50-9
    Price: $318/5mg
    (3,4-Dihydroxyphenyl)methyl 3-(beta-D-glucopyranosyloxy)-4-hydroxybenzoate

    Catalog No: CFN95531
    CAS No: 877461-90-0
    Price: $318/10mg
    Protocatechuoylcalleryanin-3-O-beta-glucopyranoside

    Catalog No: CFN95610
    CAS No: 1263431-59-9
    Price: $318/10mg
    Caffeoylcalleryanin

    Catalog No: CFN95532
    CAS No: 20300-49-6
    Price: $318/10mg
    2-(4-Hydroxyphenyl)ethanol

    Catalog No: CFN98792
    CAS No: 501-94-0
    Price: $30/20mg
    Acta Diabetol. 2017 Jan;54(1):73-79.
    Acetagastrodin effects on retinal oscillatory potentials in patients during the early stages of diabetes.[Pubmed: 27650536 ]
    To investigate the protective effect of Acetagastrodin on visual electrophysiology in patients with early-stage diabetes.
    METHODS AND RESULTS:
    A prospective, randomized, controlled, double-blind trial was conducted. Subjects who were randomly assigned to either the treatment group or the control group were orally administered Acetagastrodin or placebo, respectively, for 6 months. The quantity, mean amplitude and mean latency of oscillatory potentials (OPs) wavelets at baseline and 6 months were measured on electroretinogram (ERG), in all subjects. A total of 92 right eyes in 92 patients with type 2 diabetes, who were diagnosed for the first time, were enrolled. Each group consisted of 46 cases (46 eyes). There was no significant difference in baseline characteristic between treatment and control groups at baseline, but quantity in treatment group was more than that in control group at 6 months (P = 0.001). The mean amplitude of OPs was reduced in the control group 6 months later compared with treatment group (P = 0.001). As to mean latency of OPs, statistical difference was also detectable between the treatment group and control group 6 months later (P < 0.001). No statistical differences were found in hemoglobin between both groups at 6 months (P > 0.05).
    CONCLUSIONS:
    Electrophysiological changes would go on worsening even hemoglobin was under control during the initial stage of diabetes. Acetagastrodin treatment may be an effective treatment to protect retinal neurons against such functional impairment during the early stages of diabetes.
    6''-O-Acetylsaikosaponin D

    Catalog No: CFN95090
    CAS No: 64340-45-0
    Price: $288/5mg
    Momordicine V

    Catalog No: CFN95164
    CAS No: 1012315-36-4
    Price: $463/5mg
    Bergaptol-beta-glucopyranoside

    Catalog No: CFN95186
    CAS No: 131623-13-7
    Price: $318/10mg
    Polygalacin D2

    Catalog No: CFN95241
    CAS No: 66663-92-1
    Price: $413/5mg
    Phyllanthusiin C

    Catalog No: CFN95260
    CAS No: 142674-52-0
    Price: $318/5mg
    Indolelactic acid

    Catalog No: CFN95263
    CAS No: 1821-52-9
    Price: $100/20mg
    Quercetin 3,5-O-diglucoside

    Catalog No: CFN95486
    CAS No: 206257-35-4
    Price: $368/10mg
    4-O-Coumaroylquinic acid

    Catalog No: CFN95508
    CAS No: 53539-37-0
    Price: $318/5mg
    Ganosinensic acid C

    Catalog No: CFN95567
    CAS No: 2231756-23-1
    Price: $413/5mg
    Methyl ganoderate D

    Catalog No: CFN95581
    CAS No: 97210-12-3
    Price: $318/5mg